journal
https://read.qxmd.com/read/38360216/vascular-tumors-of-intermediate-malignancy-an-update
#21
REVIEW
Andrew L Folpe
The term "hemangioendothelioma" is used for endothelial neoplasms of intermediate malignancy and describes a group of rare neoplasms having biologic behavior falling in between that of the benign hemangiomas and fully malignant angiosarcomas. The hemangioendotheliomas fall into several specific, clinicopathologically and genetically distinct entities, specifically epithelioid hemangioendothelioma, kaposiform hemangioendothelioma, papillary intralymphatic angioendothelioma and retiform hemangioendothelioma (hobnailed hemangioendothelioma), pseudomyogenic hemangioendothelioma, composite hemangioendothelioma, and YAP1::TFE3-fused hemangioendothelioma...
February 13, 2024: Human Pathology
https://read.qxmd.com/read/38311185/dedifferentiation-in-bone-and-soft-tissue-sarcomas-how-do-we-define-it-what-is-prognostically-relevant
#22
REVIEW
Sarah M Dry
Dedifferentiation traditionally is defined by descriptive criteria as a tumor showing an abrupt change in histology from a conventional, classic, low-grade appearing neoplasm to a tumor that is more cellular, pleomorphic and "high grade", with grading typically being performed by subjective criteria. The dedifferentiated areas range from areas with recognizable histologic differentiation which differs from the primary tumor (such as an osteosarcoma arising from a low-grade chondrosarcoma) to areas containing sarcomas without specific histologic differentiation (such as pleomorphic or spindle cell sarcoma)...
February 2, 2024: Human Pathology
https://read.qxmd.com/read/38307341/histones-and-their-practical-application-in-bone-tumors-do-i-always-need-them
#23
REVIEW
John D Reith
Historically, the diagnosis of giant cell-rich neoplasms arising in bone has been challenging owing to overlapping clinical and radiographic findings resulting in the difficult separation of several neoplasms, particularly when biopsy material is limited. However, with the discovery of the driver histone mutations in giant cell tumor of bone (GCTB) and chondroblastoma, as well as USP6 rearrangements in aneurysmal bone cyst, pathologists now have objective ancillary tools to aid in the separation of several histologically similar giant cell-rich neoplasms...
February 1, 2024: Human Pathology
https://read.qxmd.com/read/38301963/enteroblastic-cholangiocarcinoma-an-uncommon-underrecognized-subtype-of-bile-duct-cancer
#24
JOURNAL ARTICLE
Jihyun Chun, Michelle Moore, Paul Kelly, Maki Kanzawa, Tomoo Itoh, Seung-Mo Hong, Yoh Zen
Enteroblastic carcinoma is clinically characterized by an elevated serum level of alpha-fetoprotein (AFP) and is histologically characterized by cancer cells with a clear cytoplasm and 'blastic' coarse chromatin. It sometimes has an element of hepatoid carcinoma; therefore, these two neoplasms are often regarded as sister entities. Although hepatoid carcinoma in the biliary tree has been reported, enteroblastic cholangiocarcinoma is extremely uncommon. In the present study, four cases of enteroblastic cholangiocarcinoma were examined...
January 30, 2024: Human Pathology
https://read.qxmd.com/read/38301962/optical-genomic-mapping-is-a-helpful-tool-for-detecting-ccnd1-rearrangements-in-cd5-negative-small-b-cell-lymphoma-two-cases-of-leukemic-non-nodal-mantle-cell-lymphoma
#25
JOURNAL ARTICLE
Andres E Quesada, Shimin Hu, Shaoying Li, Gokce A Toruner, Qing Wei, Sanam Loghavi, Chi Young Ok, Preetesh Jain, Beenu Thakral, O Valentine Nwogbo, Do Kim, Swaminathan P Iyer, M James You, L Jeffrey Medeiros, Guilin Tang
Optical genome mapping (OGM) is a new DNA-based technology which provides comprehensive examination of the entire genome. We report two patients who presented with splenomegaly and leukocytosis with lymphocytosis including villous lymphocytes. Neither patient had lymphadenopathy. Bone marrow evaluation showed involvement by small B-cell lymphoma in a sinusoidal and interstitial distribution, and immunophenotypic analysis showed that the neoplastic cells were positive for B-cell markers and cyclin D1 but were negative for SOX11 and CD5...
January 30, 2024: Human Pathology
https://read.qxmd.com/read/38280658/updates-on-who-classification-for-small-round-cell-tumors-ewing-sarcoma-vs-everything-else
#26
REVIEW
Carina A Dehner, Alexander J Lazar, John S A Chrisinger
The WHO Classification of Soft Tissue and Bone Tumours currently recognizes four categories of undifferentiated small round cell sarcoma: Ewing sarcoma, round cell sarcoma with EWSR1-non-ETS fusions including NFATc2 and PATZ1, CIC-rearranged sarcoma, and sarcoma with BCOR genetic alterations. These neoplasms frequently pose significant diagnostic challenges due to rarity and overlapping morphologic and immunohistochemical findings. Further, molecular testing, with accompanying pitfalls, may be needed to establish a definitive diagnosis...
January 26, 2024: Human Pathology
https://read.qxmd.com/read/38280657/update-on-the-role-of-pathology-and-laboratory-medicine-in-diagnosing-periprosthetic-infection
#27
REVIEW
Fermina M Mazzella, Yaxia Zhang, Thomas W Bauer
Technological and implant design advances have helped reduce the frequency of aseptic total joint arthroplasty failure, but periprosthetic joint infections (PJI) remain a clinical important problem with high patient morbidity. Misinterpreting PJI as aseptic mechanical loosening commonly leads to unsatisfactory revision arthroplasty, persistent infection, and poor long-term results. While there is no single "gold standard" diagnostic test for PJI, recent collaborative efforts by Orthopaedic and Infectious Disease Societies have developed algorithms for diagnosing PJI...
January 25, 2024: Human Pathology
https://read.qxmd.com/read/38278449/gradual-and-synergistic-correlation-of-tumor-thickness-and-histological-grade-in-penile-invasive-carcinomas
#28
JOURNAL ARTICLE
Isabel Alvarado-Cabrero, María José Fernández-Nestosa, Raquel Valencia-Cedillo, César Urizar, Sofía Cañete Portillo, Diego F Sánchez, Antonio L Cubilla
Histological grade and depth of invasion are among the best outcome pathological predictors in penile cancer. The TNM system is based on a combination of both for some stages. It is assumed that high-grade and deep tumors carry the worst prognosis, and the opposite occurs with superficial and low-grade neoplasms. However, there is no systematic evaluation of the phenomenon. We studied 147 patients from the Hospital de Oncologia - Instituto Mexicano del Seguro Social (period 2000 to 2013). They were treated by total or partial penectomies...
January 24, 2024: Human Pathology
https://read.qxmd.com/read/38423222/mucin-phenotype-and-genetic-alterations-in-non-v600e-braf-mutated-colorectal-cancer
#29
JOURNAL ARTICLE
Hikaru Ozeki, Yoshifumi Shimada, Mae Nakano, Shuhei Kondo, Riuko Ohashi, Yamato Miwa, Daisuke Yamai, Akio Matsumoto, Kaoru Abe, Yosuke Tajima, Hiroshi Ichikawa, Jun Sakata, Yasumasa Takii, Mika Sugai, Takahiro Nagai, Yiwei Ling, Shujiro Okuda, Toshifumi Wakai
Colorectal cancer (CRC) is a heterogeneous disease that develops through stepwise accumulation of genetic alterations and progresses via several distinct pathways. However, the tumorigenesis of CRCs with BRAF non-V600E mutations remains unclear. Here, we aimed to elucidate the tumorigenesis of CRCs with BRAF non-V600E mutations, focusing on differences in mucin phenotype and genetic alterations between CRCs with non-V600E and V600E mutations. We investigated 201 patients with CRC and performed panel testing of 415 genes to identify BRAF mutations...
March 2024: Human Pathology
https://read.qxmd.com/read/38340966/actual-encounters-of-the-kidney-kind-exploring-48-cases-of-renal-collision-tumors-through-the-lens-of-literature
#30
JOURNAL ARTICLE
L Angelica Lerma, Garrison Pease, James Malleis, Tatjana Antic, Ondrej Hes, Maria Tretiakova
Multiple tumors of different lineages merging into a single mass, termed collision tumors, are considered a rare phenomenon in the kidney. Tumor components, or partners, may be malignant (including metastatic disease), borderline, or benign. We report the largest cohort to date of 48 cases. The cases were identified from the archives of three institutions in the last 16 years, including 43 (90%) with 2 tumor partners (dyad) and 5 (10%) with 3 partners (triad), totaling 101 individual neoplasms. The majority of cases involved immunohistochemical workup, and 5 underwent FISH or molecular studies...
March 2024: Human Pathology
https://read.qxmd.com/read/38336278/spinal-calcifying-pseudoneoplasm-of-the-neuraxis-capnon-associated-with-facet-joint-pathologies-capnon-diagnostic-and-pathogenic-insights
#31
JOURNAL ARTICLE
Faiha Fareez, Sultan Yahya, Crystal Fong, Jinesa Moodley, John Provias, Snezana Popovic, Aleksa Cenic, Jian-Qiang Lu
Calcifying pseudoneoplasm of the neuraxis (CAPNON) is a rare tumor-like fibro-osseous lesion that can develop anywhere in the neuraxis. Approximately a half of reported CAPNONs developed in the spinal region, mostly close to the facet joint (FJ). The diagnosis of spinal CAPNONs is challenging given the existence of mimics and associated pathologies including calcific degeneration of the FJ ligaments (DFJL) and synovial cysts (SCs). The pathogenesis of CAPNON remains elusive, although there have been a few hypotheses including degenerative, reactive, proliferative and immune-mediated processes...
March 2024: Human Pathology
https://read.qxmd.com/read/38311186/residual-pure-intralymphatic-carcinoma-component-only-lymphovascular-tumor-emboli-without-invasive-carcinoma-after-neoadjuvant-chemotherapy-is-associated-with-poor-outcome-not-pathologic-complete-response
#32
REVIEW
Hyunwoo Lee, Yunjeong Jang, Yoon Ah Cho, Eun Yoon Cho
Residual pure intralymphatic carcinoma (PIC) component only after neoadjuvant chemotherapy (NAC) is lymphovascular tumor emboli without invasive carcinoma and extremely rare form of residual tumor after NAC. Although several studies have been published, the prognostic influence of residual PIC component only had not been fully evaluated. This study aims to evaluate the clinicopathologic features and the prognostic value of residual PIC component only. We reviewed the 251 patients with no residual invasive carcinoma in breast after NAC and found 12 patients with residual PIC component only after NAC...
March 2024: Human Pathology
https://read.qxmd.com/read/38262580/a-comparative-evaluation-of-trps1-and-gata3-in-adenoid-cystic-secretory-and-acinic-cell-carcinomas-of-the-breast-and-salivary-gland
#33
COMPARATIVE STUDY
Alireza Salem, Yun Wu, Constance T Albarracin, Lavinia P Middleton, Neda Kalhor, Yan Peng, Xiao Huang, Phyu P Aung, Hui Chen, Aysegul A Sahin, Qingqing Ding
GATA3 is the most used marker to determine tumors' breast origin, but its diagnostic value in triple-negative breast cancer (TNBC) is limited. The newly identified TRPS1 is highly sensitive and specific for breast carcinoma, especially TNBC. Here, we compared the utility of TRPS1 and GATA3 expression in a subset of salivary gland-type breast tumors (including adenoid cystic, acinic cell, and secretory carcinomas [AdCC, ACC, and SC, respectively]), and we compared TRPS1 and GATA3 expression of such tumors with head and neck (H&N) and AdCC of upper respiratory tumors...
March 2024: Human Pathology
https://read.qxmd.com/read/38307342/swi-snf-chromatin-remodeling-complex-in-pancreatic-ductal-adenocarcinoma-clinicopathologic-and-immunohistochemical-study
#34
JOURNAL ARTICLE
Irene Y Chen, Mark G Ettel, Phoenix D Bell, Aaron R Huber, Jennifer J Findeis-Hosey, Wenjia Wang, Aram F Hezel, Richard F Dunne, Michael G Drage, Diana Agostini-Vulaj
The SWItch/Sucrose Non-Fermentable (SWI/SNF) complex is a multimeric protein involved in transcription regulation and DNA damage repair. SWI/SNF complex abnormalities are observed in approximately 14-34 % of pancreatic ductal adenocarcinomas (PDACs). Herein, we evaluated the immunohistochemical expression of a subset of the SWI/SNF complex proteins (ARID1A, SMARCA4/BRG1, SMARCA2/BRM, and SMARCB1/INI1) within our PDAC tissue microarray to determine whether SWI/SNF loss is associated with any clinicopathologic features or patient survival in PDAC...
February 2024: Human Pathology
https://read.qxmd.com/read/38278450/pd-l1-testing-in-metastatic-triple-negative-breast-cancer-interobserver-and-interplatform-reproducibility-of-ce-ivd-assays-for-cps-and-ic-scores
#35
JOURNAL ARTICLE
Mariia Ivanova, Chiara Frascarelli, Bruna Cerbelli, Maria Gemma Pignataro, Angelina Pernazza, Konstantinos Venetis, Elham Sajjadi, Carmen Criscitiello, Giuseppe Curigliano, Elena Guerini-Rocco, Paolo Graziano, Maurizio Martini, Giulia d'Amati, Nicola Fusco
PD-L1 test is recommended in different types of tumors to select patients eligible for immune checkpoint inhibitors (ICI) therapy. Several factors make this test challenging in metastatic triple-negative breast cancer (mTNBC). Different assays and platforms are available, each associated with distinct scoring systems and threshold values specific to the ICI compound used, i.e. CPS≥10 for pembrolizumab and IC ≥ 1 % for atezolizumab. Our objective was to assess the consistency of PD-L1 testing in mTNBC by examining interobserver and interassay reproducibility...
February 2024: Human Pathology
https://read.qxmd.com/read/38278448/histologic-patterns-in-prostatic-adenocarcinoma-are-not-predictive-of-mutations-in-the-homologous-recombination-repair-pathway
#36
JOURNAL ARTICLE
Jon Mahlow, Marc Barry, Daniel J Albertson, Yeon Jung Jo, Michael Balatico, Tori Seasor, Georges Gebrael, Shruti A Kumar, Nicolas Sayegh, Nishita Tripathi, Neeraj Agarwal, Umang Swami, Deepika Sirohi
Somatic or germline homologous recombination repair (HRR) pathway gene mutations are commonly detected in prostate cancer, especially in advanced disease, and are associated with response to poly (ADP-ribose) polymerase (PARP) inhibitors. In this study, we evaluated whether histological patterns are predictive of HRR pathway gene mutations. The study population comprised 130 patients with advanced prostate carcinoma who underwent comprehensive genomic profiling (CGP) of tumor tissue at a CLIA-certified laboratory...
February 2024: Human Pathology
https://read.qxmd.com/read/38244615/differentiated-high-grade-thyroid-carcinomas-diagnostic-consideration-and-clinical-features
#37
JOURNAL ARTICLE
I Tondi Resta, M A Gubbiotti, K T Montone, V A Livolsi, Z W Baloch
BACKGROUND: Differentiated high-grade thyroid carcinomas (DHGTCs) are a new diagnostic entity most recently defined in the 2022 World Health Organization's (WHO) Classification of Endocrine and Neuroendocrine Tumors. This new entity has been minimally described in the literature, and additional cases classified as such are missing. MATERIALS AND METHODS: Cases of DHGTCs diagnosed at our institution from 2012 to 2022 were identified, and the following were reviewed: cytologic and histologic diagnoses, ancillary testing, immunohistochemical staining, treatments, and patient outcomes...
February 2024: Human Pathology
https://read.qxmd.com/read/38154678/molecular-characterization-of-large-cell-calcifying-sertoli-cell-tumors-a-multi-institutional-study-of-6-benign-and-2-malignant-tumors
#38
MULTICENTER STUDY
Eman Abdulfatah, Khaleel I Al-Obaidy, Dan Robinson, Yi-Mi Wu, Amer Heider, Muhammad T Idrees, Thomas M Ulbright, Lakshmi Pryia Kunju, Angela Wu
Large cell calcifying Sertoli cell tumors (LCCSCTs) are rare testicular tumors, representing <1 % of all testicular neoplasms. Almost 40 % of patients with LCCSCTs will present in the context of the inherited tumor predisposition syndrome, the Carney complex. While most LCCSCTs are benign, 10-20 % have malignant behavior. The aim of our study was to analyze LCCSCTs for novel molecular alterations in addition to PRKAR1A mutations and to identify potential drivers for malignant progression. Eight LCCSCTs diagnosed at two institutions were included...
February 2024: Human Pathology
https://read.qxmd.com/read/38237872/non-neoplastic-bone-joint-and-soft-tissue-pathology-what-every-pathologist-should-know
#39
REVIEW
Michael J Klein
The diagnosis of bone and soft tissue tumors is a skill which requires experience across multiple disciplines while their incidence is small. By contrast, the numbers of patients with non-tumorous diseases of bones, soft tissues, and joints dwarfs primary tumors by several orders of magnitude. The ability to successfully diagnose non-neoplastic diseases requires a knowledge of bone development, structure, remodeling, imaging, and tissue processing. This review summarizes the alterations of bones, joints, and to a lesser extent soft tissues that are encountered in the practice of everyday surgical pathology...
January 17, 2024: Human Pathology
https://read.qxmd.com/read/38224873/tert-promoter-mutations-in-atypical-melanocytic-lesions-a-series-of-seven-cases-with-adverse-melanoma-specific-outcome
#40
JOURNAL ARTICLE
Reed Huber, Jonathan Lee, Lisa Borretta, Basile Tessier-Cloutier, Amy Lum, Stephen Yip, Basil A Horst
The majority of melanocytic proliferations can be readily categorized as benign or malignant based on histologic assessment under the microscope by a trained dermatopathologist. However, a subset of lesions, termed Atypical Melanocytic Proliferations (AMPs), are histologically ambiguous, leading to possible diagnostic error and suboptimal treatment. Mutations in the promoter region of the catalytic subunit of telomerase, telomerase reverse transcriptase (TERT), are commonly found in melanomas but are rare in melanocytic nevi...
January 13, 2024: Human Pathology
journal
journal
20119
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.